NCT00082082View on ClinicalTrials.gov

A Trial of Thymalfasin in Adult Patients With Hepatocellular Carcinoma

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

Not specified

Conditions
Carcinoma, Hepatocellular
Interventions
DRUG

Thymalfasin (thymosin alpha-1)

PROCEDURE

Trans arterial chemoembolization (TACE)

Trial Locations (5)

10032

Columbia University, New York

22031

Metropolitan Research, Fairfax

32610

University of Florida, Gainesville

48073

William Beaumont Hospital, Royal Oak

94115

California Pacific Medical Center, San Francisco

Sponsors
All Listed Sponsors
lead

SciClone Pharmaceuticals

INDUSTRY

NCT00082082 - A Trial of Thymalfasin in Adult Patients With Hepatocellular Carcinoma | Biotech Hunter | Biotech Hunter